Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 4, 2005 - Issue 2
Submit an article Journal homepage
390
Views
57
CrossRef citations to date
0
Altmetric
Review

Interactions between herbal and conventional medicines

Elizabeth M Williamson The School of Pharmacy, University of Reading, PO Box 228, Whiteknights, Reading, Berkshire, RG6 6AJ, UK. [email protected]
Pages 355-378 | Published online: 22 Apr 2005

Bibliography

  • COXETER P, McLAGHLAN AJ, DUKE CC, ROUFOGALIS B: Herb-drug interactions: an evidence-based approach. Curr. Med. Chem. (2004) 11(11):1513–1525.
  • ••This paper attempts to separate interactionfrom over-reaction and assesses the evidence needed to guide clinicians about H-DIs.
  • WILLIAMSON EM: Drug interactions between herbal and prescription medicines. Drug Sal: (2003) 26(15):1075–1092.
  • •A review paper assessing known H-DIs according to therapeutic category.
  • ROGERS EA, GOUGH JE, BREWER KL: Potential herb - drug interactions in an emergency department population. Academic Emergency Med. (2003) 8(5):451–456.
  • IZZO AA, BORRELLI F, CAPASSO R: Herbal medicine: the dangers of drug interaction. Trends Pharm. Sci. (2002) 23:358–359.
  • FUGH-BERMAN A, ERNST E: Herb - drug interactions: review and assessment of report reliability. Br. J. Clin. Pharm. (2001) 52:587–595.
  • ••A pivotal paper addressing the subjectof report reliability.
  • LIN YC, BIOTEAU AB, FERRARI LR, BERDE CB: The use of herbs and complementary medicine in pediatric preoperative patients. J. Clin. Anesthes. (2004) 16(1):4–6.
  • KAUFFMAN DW, KELLY JP, ROSENBERG L, ANDERSON TE, MITCHELL AA: Recent patterns of medication use in the ambulatory adult population of the United States. JAMA (2002) 287:337–344.
  • ••A comprehensive assessment of incidenceof consumption of herbal medicines in the US.
  • ERNST E: Serious psychiatric and neurological adverse effects of herbal medicines - a systematic review. Acta Psychiatr. Scand. (2003) 108:83–91.
  • SMITH L, ERNST E, EWINGS P, MYERS S, SMITH C: Co-ingestion of herbal products with warfarin. Br. J. an. Prac. (2004) 54:439–441.
  • •This paper reports a questionnaire study showing the extent to which patients take herbal medicines along with warfarin.
  • MANSOOR G: Herbs and alternative therapies in the hypertension clinic. Am. J. Hypertension (2002) 14:971–975.
  • BARNES J, MILLS SY, ABBOTT NC, WILLOUGHBY M, ERNST E: Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal medicines. Br. J. Clin. Pharmacol (1998) 45:496–500.
  • •This paper highlights differences in perception as to whether herbal medicines are drugs.
  • SPARREBOOM A, COX MC, ACHARYA MR, FIGG W: Herbal remedies in the United States: potential adverse interactions with anticancer agents. J. Chi]. Oncology (2004) 22(12)2498–2503.
  • ••This is a useful overview of the literatureconcerning reported interactions of herbal drugs with anticancer agents, an area where drug dosage is critical.
  • BUTTERWECK V, DARENFORF H, GAUS W, NARSTEDT A, SCHULZ V, UNGER M: Pharmacokinetic herb - drug interactions: are preventative screenings necessary and appropriate? Planta Med. (2004) 70:784–791.
  • GORSKI JC, HUANG S-M, PINTO MD et al: The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. OM. Pharm. Ther. (2004) 75(1):89–100.
  • GURLEY WJ, GARDNER SF, HUBBARD MA et al: Cytochrome P450 phenotypic ratios for predicting herb - drug interactions in humans. Clin. Pharm. Ther. (2002) 72(3):276–287.
  • ••An important study predicting H-DIsfrom phenotype rations. It shows SBA/ increases the induction of some CYP enzymes significantly more in female than male subjects.
  • WILLIAMSON EM: Synergy and other interactions in phytomedicines. Phytomedicine (2001) 8(0401–40.
  • •This is a widely cited review paper documenting the types of interaction taking place with herbal medicines, showing their complexity and possible synergistic interactions.
  • BUDZINSKI JW, FOSTER BC, VANDENHOEK S, ARNASON JT: An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomed. (2000) 7(4):273–282.
  • •One of the first serious attempts to look at the potential of a range of popular herbal medicines to induce CYP450 enzymes in vitro.
  • ZHOU S, GAO Y, HUANG M, XU A, PAXTON JW: Interactions of herbs with cytochrome P450.Drug Metab. Rev. (2003) 35 (1) :35–98.
  • ••This is a very comprehensive discussion ofthe issues surrounding the induction of metabolic enzymes, which are involved in H-DIs.
  • ZHOU S, LIM LY, CHOWBAY B: Herbal modulation of P-glycoprotein. Drug Metab. Rev (2004) 36(1):1–48.
  • ••A companion paper to [19] concerningP-glycoprotein, and equally comprehensive.
  • FOSTER BC, FOSTER MS, VANDENHOEK S et al.: An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. Pharm. Pharmaceut. Li. (2001) 4(2):176–184.
  • UENG Y-F, CHEN R-M: The role of cytochrome P450 in herb - drug interactions. Curr. Pharmacogenomics (2004) 2(2):2090218.
  • DEFERME S, AUGUSTIJNS P: The effect of food components on the absorption of P-gp substrates: a review. J. Pharm. Pharmacol (2002) 55:153–162.
  • ZHOU S, KOH H-L, GAO Y, GONG Z, LEE EJ: Herbal bioactivation: the good, the bad and the ugly. Life Sci. (2004) 74(8):935–968.
  • MORIMOTO T, KOTEGAWA T, TSUTSUMI K, OHTANI Y, IMAI H, NAKANO S: Effect of St John's wort on the pharmacokinetics of theophylline in healthy volunteers. J. Clin. Pharmacol (2004) 44(1):95–101.
  • NEBEL A, SCHNEIDER BJ, BAKER RK, KROLL DJ: Potential metabolic interaction between St John's wort and theophylline. Ann. Pharmacother. (1999) 33:502.
  • ROLAN PE: Plasma protein binding displacement interactions - why are they still regarded as clinically important? Br. J. Clin. Pharm. (1994) 37(2):125–128.
  • SCHMIDT LE, DALHOFF K: Food - drug interactions. Drugs (2002) 62:1481–1502.
  • SORENSEN JM: Herb - drug, food - drug, nutrient-drug, and drug-drug interactions: mechanisms involved and their medical implications. J. Alt. Comp. Med. (2002) 8:293–308.
  • MOLLER RS, BREITKREUTZ R, GRONING R: Interactions between aqueous Hypericum perforatum extracts and drugs: in vitro studies. Phytother. Res. (2004) In press.
  • •The first paper of its type showing that the method of production of a herbal extract can influence enzyme induction in vitro.
  • MAT I, BAUER S, PERLOFF ES, JOHNE A et al.: Hyperforin content determines the magnitude of the SJW-cyclosporine drug interaction. Clin. Pharm. Ther. (2004) 76(4):330–340.
  • LOEW D, KASZKIN M: Approaching the problem of bioequivalence of herbal medicinal products. Phytother. Res. (2002) 16(8):705–712.
  • •A good explanation of the issues surrounding bioequivalence of herbal medicinal products.
  • MAKINA K, WAKUSHIMA H, OKAMOTO T et al.: Pharmacokinetic interactions between warfarin and kangen-karyu, a traditional Chinese medicine, and their synergistic action. J. Ethnopharmacol (2002) 82:35–40.
  • SARUWATARI J, HISAEDA S, HIGA Y, TOMIYASU Y, NAKAGAWA K, ISHIZAKI T: The in-vivo effect of bakumondo-to (TJ-29), a traditional Japanese medicine used for treatment of chronic airway disease, on cytochrome P450 1A2, xanthine oxidase and Nacetyltransferase 2 activity in man. Pharm. Pharmacol (2004) 56:1171–1177.
  • TAKASHI K, UEJIMA E, MORISAKI T, KUROKAWA N, AZUMA J: LI vitro inhibitory effects of Kampo medicines on metabolic reactions controlled by human liver microsomes.Pharm. Ther. (2003) 28(4):319–327.
  • NOSE M, TAMURA M, RYU N, MIZUKAMI H, OGIHARA Y: Sho-saiko-to and Saikoko-keisi-to, the traditional Chinese and Japanese herbal medicines, altered hepatic drug-metabolizing enzymes in mice and rats when administered orally for a long time. J. Pharm. Pharmacol (2003) 55(10):1419–1426.
  • WANG M, LAMERS R-J AN, KORTHOUT HA et al: Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother. Res. (2004) In press.
  • ABEBE W: Herbal medication: potential for adverse interactions with analgesic drugs. J. Clin. Pharm. Ther. (2002) 27(6):391–401.
  • ANG-LEE MK, MOSS J, YAUN C: Herbal medicines and pen-operative care. JAMA (2001) 286:208–216.
  • BARONE GW, GURLEY BJ, KETEL BL et al.: Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation (2001) 71:239–241.
  • VALLI G, GIARDIANA E-GV: Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. Am. Coll. Cardiol (2002) 38:1083–1095.
  • IZZO AA, ERNST E: Interactions between herbal medicines and prescribed drugs. A systematic review. Drugs (2001) 61:2163–2175.
  • AWANG DV, FUGH-BERMAN A: Herbal interactions with cardiovascular drugs. Cardiovasc. Nursing (2003) 16(4):64–70.
  • UPTON R (Ed): Chaste Tree Fruit. In: American Herbal Pharmacopeia and Therapeutic Compendium. (2001) AHP, Santa Cruz, CA, USA 32–33.
  • RAO A, KARANTH KS: Neuropharmacological activity of Withania somnifera. Fitoterapia (1990) 61(0:237–240.
  • KULKARNI SK, GEORGE B, MATHUR R: Protective effect of Withania somnifera root extract on electrographic activity in a lithium-pilocarpine model of status epilepticus. Phytother. Res. (1998) 12(0:451–453.
  • UPTON R (Ed): Astragalus. In: American Herbal Pharmacopeia and Therapeutic Compendium. AHP, Santa Cruz, CA, USA (1999):20–21.
  • MILLS S, BONE K: Principles and Practice of Phytotherapy. Churchill Livingstone, Edinburgh, UK (2000):280–285.
  • •An authoritative text covering all aspects of herbal medicine.
  • LISKE P: Therapeutic efficacy and safety of Cimicifuga racemosa for gynaecological disorders. Adv. Ther. (1998) 15(1):45–53.
  • LAMBERT JP, CORMIER A: Potential interaction between warfarin and boldo-fenugreek. Pharmacother. (2001) 21:509–512.
  • DONOVAN JL, DEVANE CL, BOULTON D, DODD S, MARKOWITZ JS: Dietary levels of quinine in tonic water do not inhibit CYP2D6 in vivo. Food Chem. Toxicol 0003) 42 (8):1199–1201.
  • PAGE RL, LAWRENCE JD: Potentiation of warfarin by dong quai. Pharmacother. (1999) 19(7):870–876.
  • LO ACT, CHAN K, YEUNG JH: Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits. Eur. J. Drug Metab. Pharmacokinet. (1995) 20:55–60.
  • GAO G. YANG J: Synergistic effect of Angelica sinensis with cyclophosphamide in treating transplanted tumours of mice. Zhongghuo Yiyan YaoXue Zazhi (1997) 17(7):304–305.
  • MCCOUBRIE M: Doctors as patients: lisinopril and garlic. Br. J. Gen. Pract. (1996) 46:107.
  • SUGIYAMA T, KUBOTA Y, SHINOZUKA K, YAMADA S, YAMADA K, UMEGAKI K: Induction and recovery of hepatic drug metabolizing enzymes in rats treated with Ginkgo biloba extract. Food Chem. Toxicol (2004) 42:953–957.
  • GALLUZI S, NANETTI 0, BINETTI G et al: Coma in a patient with Alzheimer's disease taking low-dose trazodone and Ginkgo biloba. I Neurol Neurosurg. Psychiatry (2000) 68:679–683.
  • JONES BD, RUNIKIS AM: Interaction of ginseng with phenelzine. I Clin. Psychopharmacol (1987) 7:201–202.
  • YUAN C-S, WEI G, DEY L et al: American ginseng reduces warfarin's effect in healthy patients. A randomized, controlled trial. Ann. Int. Med. (2004) 141 (1):123–126.
  • JIANG X, WILLIAMS KM, LIAUW WS et al: Effects of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. BE J. Clin. Pharmacol (2004): 57(5):592–599.
  • FOSTER BC, VANDENHOEK S, HANA J et al: In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomed. (2003) 10(4):334–342.
  • CHATTERJEE P, FRANKLIN M: Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab. Dispos. (2003) 31(11):1391–1397.
  • SANDHU RS, PRESCILLA RP, SIMONELLI TM, EDWARDS DJ: Influence of goldenseal root on the pharmacokinetics of indinavir. 1 Clin.Pharmacol (2003) 43(11):1283–1288.
  • DONOVAN JL, DEVANE CL, CHAVIN KD et al: Green tea (Camellia sinensis) extract does not alter cytochrome P450 3A4 or 2D6 in healthy volunteers. Drug Metab. Disp. (2004) 32(9):906–908.
  • DICENZO R, SHELTON M, JORDAN K et al: Co-administration of milk thistle and indinavir in healthy subjects. Pharmacother. (2003) 23(7):866–870.
  • PISCITELLI SC, FORMENTINI E, BURSTEIN AH et al: Effect of milk thistle on the pharmacokinetics of indinavir in healthy subjects. Pharmacother. (2002) 22(5):551–556.
  • SUGOMOTO K, OHMORI M, TSURUOKA S et al: Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Pharmacol Ther. (2001) 70(6):518–524.
  • ZHOU S, CHAN E, PAN S-Q, HUANG M, LEE EJ: Pharmacokinetic interactions of drugs with St John's wort. J. Psychopharmacol (2004) 18(2):269–283.
  • WANG EJ, BARECKI-ROACH M, JOHNSON WW: Quantitative characterization of direct P-glycoprotein inhibition by St John's wort. Pharm. Pharmacol (2004) 56(1):123–128.
  • HEBERT ME PARK JM, CHEN Y-L, AKHTAR S, LARSON AM: Effects of St John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J. Clin. Pharmacol (2004) 44(1):89–94.
  • WANG LS, ZHOU G, ZHU B et al: St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin. Pharmacol Ther. (2004) 75(4):191–197.
  • TANNERGREN C, ENGMAN H, KNUTSON L, HEDELAND M, BONDESSON U, LENNERNAS H: St John's wort decreases the bioavailability of R- and S- verapamil through induction of the first-pass metabolism. Clin. Pharmacol Ther. (2004) 75(4):298–309.
  • MORIMOTO T, KOTEGAWA T, TSUTSUMI K, OHTANI Y, IMAI H, NAKANO S: Effect of St John's wort on the pharmacokinetics of theophylline in healthy human volunteers.Pharmacol (2004) 44(1):95–101.
  • MARKOWITZ JS, DONOVAN JL, DE VANE CL et al.: Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin. Pharmacol Ther. (2003) 74(6):536–542.
  • LIU GT: Pharmacological actions and clinical uses of Fructus schizandrae. In: Recent advances in Chinese Herbal drugs - actions and uses. Zhou J, Liu GT, Chen J (Eds), Beijing Science Press (1990:100–111.
  • STRANDELL J, NEILL A, CARLIN G: An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomed. (2004) 11(2–3):98-104.A new experimental approach to investigating the interaction potential of herbs.
  • LEFEBVRE T, FOSTER B, DROUIN C et al.: hi vitro activity of commercial valerian root extracts against human cytochrome P450 3A4.j Pharm. Pharmaceut. Li. (2004) 7(2):265–273.
  • HENDRIKS H, BOS R, WOERDENBAG HJ, KOSTER AS: Central nervous depressant activity of valerenic acid in the mouse. Planta Med. (1985) 51:28–31.
  • LEUSCHNER J, MUELLER J, RUDMANN M: Characterization of the central nervous depressant activity of a commercially available valerian root extract. Arzneim. Forsch. (1993) 43:638–644.
  • DONOVAN JL, DEVANE CL, CHAVIN KD et al.: Multiple night-time doses of Valerian ( Valeriana officinalis) had minimal effect on CYP3A4 activity, and no effect on CYP2D6 activity in healthy volunteers. Drug Metab. Disp. (2004) In press.
  • JANETSKY K, MORREALE JP: Probable interaction between warfarin and ginger. Am. J. Health-Syst. Pharm. (1997) 54:692–693.
  • HOFFMANN T: Ginkgo, Vi0XX and excessive bleeding - possible drug interactions: case report. Hawaii Med. (2001) 60:290.
  • ENGELSON J, NIELSEN JD, HANSEN KF: Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial. Ugeskr. Laeger (2003) 165:1868–1871.
  • TOUTONG M, SCHULTZ P, WIDMER J et al: Probable interaction entre le psyllium et le lithium. Therapie (1990) 45:357–360.
  • HUUPONEN R, SEPPALA P, IISALO E: Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man. Fur. J. Clin. Pharmacol (1984) 26:279–281.
  • BAILEY DG, DRESSER GK, BEND JR: Bergamottin, lime juice and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin. Pharmacol Ther. (2004) 75(4):362–363.

Websites

  • www.timesonline.co.uldprintFriendly/ 0,1-2-1166505,00.html Times online (2004), Alert over fatal mix of herbal pills and medicines.
  • http://www.who-umc.org The Uppsala Monitoring Centre website (2005).
  • http://medicines.mhra.gov.uldourworld monitorsafequalmed/currentproblems/ currentproblems.htm Monitoring safety and quality of medicines: Current Problems in Pharmacovigilance (2004).
  • http://www.mhra.gov.uk Website of the Medicines and Healthcare products Regulatory Agency, UK.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.